The association between the poly(A) polymorphism in the VDR gene and cancer risk: A meta-analysis

Tumor Biology

Volumn 34, Issue 3, 2013, Pages 1833-1838

  Huang, Jin ^a   Yang, Jiqiao ^a   Wang, Haichuan ^a   Xiong, Tianyuan ^a   Zhang, Hongbo ^b   Ma, Yaxian ^a   Wang, Xiaoze ^a   Huang, Jichong ^a   Du, Liang ^a  

^a SICHUAN UNIVERSITY   (China)

^b CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Cancer; Meta analysis; Poly(A); Polymorphism; Vitamin D receptor

Indexed keywords

POLYADENYLIC ACID; VITAMIN D RECEPTOR;

AFRICAN AMERICAN; ALLELE; ARTICLE; ASIAN; BREAST CANCER; CANCER RISK; CAUCASIAN; COLORECTAL CANCER; CONTROLLED STUDY; ESOPHAGUS CANCER; ETHNICITY; GENETIC ASSOCIATION; HETEROZYGOTE; HISPANIC; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; POLYADENYLIC ACID GENE; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE; VITAMIN D RECEPTOR GENE;

EID: 84878712801     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-0724-0     Document Type: Article

References (24)

1. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008;7:11-20.
2. Yang S, Jia C, Zhu H, Han S. Cyp1a1 ile462val polymorphism and cervical cancer: evidence from a meta-analysis. Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine. 2012;33:2265-72.
3. Chang CK, Mulholland H, Cantwell M, Anderson L, Johnston B, McKnight A, et al. Vitamin D receptor gene variants and esophageal adenocarcinoma risk: a population-based case-control study. J Gastrointest Cancer. 2012;43:512-7.
4. Wedren S, Magnusson C, Humphreys K, Melhus H, Kindmark A, Stiger F, et al. Associations between androgen and vitamin D receptor microsatellites and postmenopausal breast cancer. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2007;16:1775-83.
5. Bai YH, Lu H, Hong D, Lin CC, Yu Z, Chen BC. Vitamin D receptor gene polymorphisms and colorectal cancer risk: a systematic meta-analysis. World J Gastroenterol. 2012;18:1672.
6. Arjumand W, Ahmad ST, Seth A, Saini AK, Sultana S. Vitamin D receptor FOKI and BSMI gene polymorphism and its association with grade and stage of renal cell carcinoma in North Indian population. Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine. 2012;33:23-31.
7. Zhuo X, Zhao H, Chang A, Ye H, Zhou Y, Song Y, et al. Cytochrome p450 1a1 ile462val polymorphism and oral carcinoma risk: an updated meta-analysis including 1,515 cases and 2,233 controls. Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine. 2012;33:2079-89.
8. Zhang H, Xu Y, Zhang Z, Li L. The hogg1 ser326cys polymorphism and prostate cancer risk: a meta-analysis of 2584 cases and 3234 controls. BMC Cancer. 2011;11:391.
9. Liu J, Liao Q, Zhang Y, Sun S, Zhong C, Liu X. Cyclin d1 g870a polymorphism and lung cancer risk: a meta-analysis. Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine. 2012;33:1467-76.
10. Blazer DG, Umbach DM, Bostick RM, Taylor JA. Vitamin D receptor polymorphisms and prostate cancer. Mol Carcinog. 2000;27:18-23.
11. Chakraborty A, Mishra AK, Soni A, Regina T, Mohil R, Bhatnagar D, et al. Vitamin D receptor gene polymorphism(s) and breast cancer risk in North Indians. Cancer Detect Prev. 2009;32:386-94.
12. Cheteri MBK, Stanford JL, Friedrichsen DM, Peters MA, Iwasaki L, Langlois MC, et al. Vitamin D receptor gene polymorphisms and prostate cancer risk. Prostate. 2004;59:409-18.
13. Correa-Cerro L, Berthon P, Häussler J, Bochum S, Drelon E, Mangin P, et al. Vitamin D receptor polymorphisms as markers in prostate cancer. Hum Genet. 1999;105:281-7.
14. Flügge J, Laschinski G, Roots I, Krusekopf S. Vitamin D receptor poly(A) microsatellite and colorectal cancer risk in caucasians. Int J Colorectal Dis. 2009;24:171-5.
15. Guy M, Lowe LC, Bretherton-Watt D, Mansi JL, Peckitt C, Bliss J, et al. Vitamin D receptor gene polymorphisms and breast cancer risk. Clin Cancer Res. 2004;10:5472-81.
16. Ingles SA, Garcia DG, Wang W, Nieters A, Henderson BE, Kolonel LN, et al. Vitamin D receptor genotype and breast cancer in Latinas (United States). Cancer Causes Control. 2000;11:25-30.
17. Ingles SA, Ross RK, Yu MC, Haile RW, Irvine RA, La Pera G, et al. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst. 1997;89:166-70.
18. Kibel AS, Isaasc SD, Isaacs WB, Bova GS. Vitamin D receptor polymorphisms and lethal prostate cancer. J Urol. 1998;160:1405-9.
19. Oakley-Girvan I, Feldman D, Eccleshall TR, Gallagher RP, Wu AH, Kolonel LN, et al. Risk of early-onset prostate cancer in relation to germ line polymorphisms of the vitamin D receptor. Cancer Epidemiol Biomarkers Prev. 2004;13:1325-30.
20. Rollison DE, Cole AL, Tung KH, Slattery ML, Baumgartner KB, Byers T, et al. Vitamin D intake, vitamin D receptor polymorphisms, and breast cancer risk among women living in the southwestern USA. Breast Cancer Res Treat. 2012;132(2):683-91.
21. Slattery ML, Samowitz W, Hoffman M, Ma KN, Levin TR, Neuhausen S. Aspirin, NSAIDS, and colorectal cancer: possible involvement in an insulin-related pathway. Cancer Epidemiol Biomarkers Prev. 2004;13:538-45.
22. Trabert B, Malone KE, Daling JR, Doody DR, Bernstein L, Ursin G, et al. Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women. Breast Cancer Res. 2007;9:R84.
23. Barbisan G, Perez LO, Contreras A, Golijow CD. Tnf-alpha and il-10 promoter polymorphisms, hpv infection, and cervical cancer risk. Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine. 2012;33:1549-56.
24. Naik NA, Bhat IA, Afroze D, Rasool R, Mir H, Andrabi SI, et al. Vascular endothelial growth factor A gene (VEGFA) polymorphisms and expression of VEGFA gene in lung cancer patients of Kashmir Valley (India). Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine. 2012;33:833-9.